| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2006 | A membrane antibody receptor for noninvasive imaging of gene expression | Roffler, S. R.; Wang, H. E.; Yu, H. M.; Chang, W. D.; Cheng, C. M.; Lu, Y. L.; Chen, B. M.; Cheng, T. L. | Gene Ther 13, 412-420 | | | |
| 2003 | Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma | Tsai, N. M.; Chen, B. M.; Wei, S. L.; Wu, C. W.; Roffler, S. R. | Clin Exp Metastasis 20, 103-109 | | | |
| 2002 | Anti-tumour activity and toxicity of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in mice | Prijovich, Z. M.; Chen, B. M.; Leu, Y. L.; Chern, J. W.; Roffler, S. R. | British Journal of Cancer 86, 1634-1638 | | | |
| 1999 | Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug | Cheng, T. L.; Wei, S. L.; Chen, B. M.; Chern, J. W.; Wu, M. F.; Liu, P. W.; Roffler, S. R. | British Journal of Cancer 79, 1378-1385 | | | |
| 1999 | Characterization of an antineoplastic glucuronide prodrug | Cheng, T. L.; Chou, W. C.; Chen, B. M.; Chern, J. W.; Roffler, S. R. | Biochem Pharmacol 58, 325-328 | | | |
| 2006 | Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines | Chuang, K. H.; Cheng, C. M.; Roffler, S. R.; Lu, Y. L.; Lin, S. R.; Wang, J. J.; Tzou, W. S.; Su, Y. C.; Chen, B. M.; Cheng, T. L. | Bioconjugate Chem 17, 707-714 | | | |
| 2007 | Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor destructive immune responses | Tuve, S.; Chen, B. M.; Liu, Y.; Cheng, T. L.; Toure, P.; Sow, P. S.; Feng, Q.; Kiviat, N.; Strauss, R.; Ni, S.; Li, Z. Y.; Roffler, S. R.; Lieber, A. | Cancer Research 67(12), 5929-5939 | | | |
| 1997 | Cure of malignant ascites and generation of protective immunity by monoclonal antibody-targeted activation of a glucuronide prodrug in rats | Chen, B. M.; Chan, L. Y.; Wang, S. M.; Wu, M. F.; Chern, J. W.; Roffler, S. R. | Int J Cancer 73, 392-402 | | | |
| 2000 | Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy | Cheng, T. L.; Chen, B. M.; Chern, J. W.; Wu, M. F.; Roffler, S. R. | Bioconjugate Chemistry 11, 258-266 | | | |
| 2000 | Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy | Chen, B. M.; Chen, J. Y.; Kao, M.; Lin, J. B.; Yu, M. H.; Roffler, S. R. | Gynecol Oncol 79, 272-280 | | | |
| 2007 | Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored beta-glucuronidase | Su, Y. C.; Chuang, K. H.; Wang, Y. M.; Cheng, C. M.; Lin, S. R.; Wang, J. Y.; Hwang, J. J.; Chen, B. M.; Chen, K. C.; Roffler, S. R.; Cheng, T. L. | Gene Ther 14(7), 565-574 | | | |
| 2004 | Hapten-directed targeting to single-chain antibody receptors | Cheng, T. L.; Liao, K. W.; Tzou, S. C.; Cheng, C. M.; Chen, B. M.; Roffler, S. R. | Cancer Gene Ther 11, 380-388 | | | |
| 2007 | Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes | Chen, K. C.; Cheng, T. L.; Leu, Y. L.; Prijovich, Z. M.; Chuang, C. H.; Chen, B. M.; Roffler, S. R. | Cancer Gene Ther 14(2), 187-200 | | | |
| 1997 | Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs | Cheng, T. L.; Chen, B. M.; Chan, L. Y.; Wu, P. Y.; Chern, J. W.; Roffler, S. R. | Cancer Immunol Immunother 44, 305-315 | | | |
| 2001 | Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy | Chen, B. M.; Cheng, T. L.; Tzou, S. C.; Roffler, S. R. | Int J Cancer 94, 850-858 | | | |
| 2003 | Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity | Liao, K. W.; Chen, B. M.; Liu, T. B.; Tzou, S. C.; Lin, Y. M.; Lin, K. F.; Su, C. I.; Roffler, S. R. | Cancer Gene Ther 10, 779-790 | | | |
| 1991 | Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates | Roffler, S. R.; Yu, M. H.; Chen, B. M.; Tung, E.; Yeh, M. Y. | Cancer Res 51, 4001-4007 | | | |
| 2003 | Tumor-associated antigen L6 and the invasion of human lung cancer cells | Kao, Y. R.; Shih, J. Y.; Wen, W. C.; Ko, Y. P.; Chen, B. M.; Chan, Y. L.; Chu, Y. W.; Yang, P. C.; Wu, C. W.; Roffler, S. R. | Clin Cancer Res 9, 2807-2816 | | | |
| 2008 | Tumor-targeting prodrug-activating bacteria for cancer therapy | Chuang, K. H.; Hung, W. C.; Shiea, J.; Su, Y. C.; Kao, C. H.; Chen, B. M.; Roffler, S. R.; Cheng, Tian-Lu | Cancer Gene Therapy 15, 393-401 | | | |
